Accountable Health Care Ipa

Accountable Health Care Ipa was paid $3.47M by Medicaid between Jan 2018 and Aug 2021, across 369 billing codes. Its largest line is 99223, Prolong inpt eval add15 m — 11% of everything it billed.

33Billing provider infoACCOUNTABLE HEALTH CARE IPA
SIGNAL HILL, CA 90755

33aNPI1114070224assigned 01/19/2007

33bProvider typeHealth Maintenance Organization

28Total paid$3.47M

24GClaims276,339

24DCodes billed369

24AFirst – last monthJan 2018 – Aug 2021

Compared with peers

Next to other Health Maintenance Organization providers in California

Rank by total paid#28 of 151

Median peer was paid$59K

This provider vs. median59×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	157,589	$2.47M
2019	4,367	$114K
2020	56,420	$386K
2021	57,963	$499K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99223	Prolong inpt eval add15 m	11%	1,006	956	$376K
99199	Unlisted special service, procedure or report	8.2%	7,017	6,399	$283K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	5.6%	7,031	6,506	$194K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.2%	7,740	7,604	$147K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	3.9%	4,063	1,265	$133K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	3.7%	3,025	3,016	$129K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.5%	32,298	29,003	$121K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.8%	1,197	1,077	$98K
59425		2.5%	1,689	1,059	$85K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	2.5%	1,683	1,677	$85K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	2.4%	668	423	$82K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	2.3%	1,774	1,760	$80K

357 more codes

99204	Doctor's office visit, new patient (more involved)	2.3%	1,346	$80K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	2.3%	2,031	$79K
82785		1.9%	419	$64K
H1001	Prenatal care, at-risk enhanced service; antepartum management	1.8%	1,038	$62K
A0429	Emergency ambulance ride, basic life support	1.7%	533	$60K
86003		1.6%	635	$56K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.6%	1,516	$56K
99215	Doctor's office visit, returning patient (complex)	1.5%	341	$52K
99244	Office or other outpatient consultation, moderate to high complexity	1.5%	706	$52K
A0427	Emergency ambulance ride, advanced life support	1.4%	447	$48K
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	1.4%	408	$48K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.3%	418	$44K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.3%	1,541	$43K
99203	Doctor's office visit, new patient (routine)	1.3%	928	$43K
88142		1.2%	888	$43K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	1.1%	72	$38K
99243		1.0%	663	$35K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	709	$30K
97010		<1%	799	$30K
0450	Emergency room services	<1%	619	$30K
J3490	Unclassified drugs	<1%	234	$29K
64493		<1%	141	$23K
E0601	Continuous positive airway pressure (cpap) device	<1%	412	$20K
92134		<1%	109	$20K
64483		<1%	56	$18K
92552		<1%	6,616	$16K
99285	Emergency room visit (most serious)	<1%	166	$15K
T4541	Incontinence product, disposable underpad, large, each	<1%	492	$15K
A0426	Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)	<1%	108	$15K
80053	Comprehensive metabolic panel	<1%	10,804	$14K
E0443	Portable oxygen contents, gaseous, 1 month's supply = 1 unit	<1%	124	$14K
99232	Hospital visit by a doctor, follow-up day	<1%	787	$14K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	290	$14K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,972	$13K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	14,498	$13K
97803		<1%	1,080	$12K
95117		<1%	1,708	$12K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	105	$12K
59409	Vaginal delivery only (with or without episiotomy and/or forceps)	<1%	25	$12K
71045	Radiologic examination, chest; single view	<1%	712	$11K
99284	Emergency room visit (serious)	<1%	153	$11K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	110	$11K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	572	$10K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,077	$10K
99283	Emergency room visit (moderate)	<1%	213	$9K
95811		<1%	25	$9K
71046	Radiologic examination, chest; 2 views	<1%	538	$9K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	126	$8K
97802		<1%	2,095	$7K
76881		<1%	64	$7K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,294	$7K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	408	$7K
92060		<1%	4,993	$6K
70450	Computed tomography, head or brain; without contrast material	<1%	48	$6K
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	<1%	316	$6K
K0001	Standard wheelchair	<1%	193	$5K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	9,612	$5K
99383		<1%	81	$5K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	270	$5K
36415	Collection of venous blood by venipuncture	<1%	5,707	$5K
90686		<1%	680	$5K
85018		<1%	4,338	$5K
80061	Lipid panel	<1%	6,120	$4K
80048	Basic metabolic panel (calcium, ionized)	<1%	3,183	$4K
59514		<1%	13	$4K
99384		<1%	61	$4K
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,248	$4K
86580		<1%	1,693	$4K
T4535	Disposable liner/shield/guard/pad/undergarment, for incontinence, each	<1%	178	$4K
59025	Fetal non-stress test	<1%	65	$4K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	184	$4K
90715		<1%	342	$4K
92250		<1%	40	$4K
95144		<1%	40	$4K
99460		<1%	46	$4K
81025		<1%	1,299	$3K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	398	$3K
84702		<1%	750	$3K
T4527	Adult sized disposable incontinence product, protective underwear/pull-on, large size, each	<1%	57	$3K
84443	Thyroid stimulating hormone (TSH)	<1%	5,373	$3K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,490	$3K
81001		<1%	2,955	$3K
92557		<1%	26	$3K
G0270	Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes	<1%	985	$3K
97162		<1%	37	$3K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	15	$3K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	100	$3K
86592		<1%	2,415	$3K
99382		<1%	42	$2K
E0570	Nebulizer, with compressor	<1%	34	$2K
76801		<1%	24	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	84	$2K
99222	Initial hospital care, per day, moderate complexity	<1%	14	$2K
87088		<1%	622	$2K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	17	$2K
81003		<1%	4,330	$2K
E0562	Humidifier, heated, used with positive airway pressure device	<1%	346	$2K
H1003	Prenatal care, at-risk enhanced service; education	<1%	414	$2K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	24	$2K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	56	$2K
T4526	Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each	<1%	48	$2K
81000		<1%	3,048	$2K
83690		<1%	1,138	$2K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	53	$2K
84484		<1%	752	$2K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	39	$2K
90651		<1%	459	$2K
A6250	Skin sealants, protectants, moisturizers, ointments, any type, any size	<1%	105	$2K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,774	$1K
97001		<1%	26	$1K
3008F		<1%	5,568	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	606	$1K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	154	$1K
88112		<1%	15	$1K
97161		<1%	24	$1K
67028	Intravitreal injection of a pharmacologic agent	<1%	15	$1K
T4523	Adult sized disposable incontinence product, brief/diaper, large, each	<1%	27	$1K
90648		<1%	293	$1K
86038		<1%	312	$1K
A4927	Gloves, non-sterile, per 100	<1%	113	$1K
82728		<1%	398	$1K
82746		<1%	294	$1K
99205	Prolong outpt/office vis	<1%	39	$1K
85610		<1%	1,699	$1K
82947		<1%	676	$1K
84439		<1%	1,516	$997.27
88141		<1%	202	$983.42
85027		<1%	1,319	$978.39
85730		<1%	1,132	$894.95
90670		<1%	581	$884.16
94760		<1%	587	$850.00
99381		<1%	13	$833.15
90700		<1%	534	$828.00
92235		<1%	28	$801.74
82784		<1%	25	$741.94
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	817	$732.17
96375	Therapeutic injection; each additional sequential IV push	<1%	29	$689.54
90707		<1%	280	$679.76
A4335	Incontinence supply; miscellaneous	<1%	64	$677.19
86900		<1%	868	$619.63
90658		<1%	365	$615.48
84703		<1%	435	$605.70
86005		<1%	28	$587.55
83540		<1%	523	$577.95
90649		<1%	205	$558.65
80076		<1%	1,098	$558.43
83880		<1%	61	$557.86
90713		<1%	326	$557.33
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	189	$540.42
83735		<1%	371	$531.50
86901		<1%	826	$527.79
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	159	$525.79
87186		<1%	523	$520.05
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	36	$512.44
90633		<1%	328	$503.22
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	26	$494.76
0250		<1%	62	$481.05
97014		<1%	1,026	$470.00
93000		<1%	297	$455.12
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	144	$447.50
92083		<1%	14	$414.15
A0425	Ground mileage, per statute mile	<1%	1,913	$404.39
85652		<1%	698	$379.30
92133		<1%	14	$376.56
87070		<1%	162	$375.95
90716		<1%	308	$371.95
90696		<1%	86	$360.00
90620		<1%	63	$352.82
99000		<1%	485	$352.59
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	185	$337.58
A7035	Headgear used with positive airway pressure device	<1%	15	$318.73
82570		<1%	771	$308.48
86803		<1%	142	$293.41
84153		<1%	619	$289.68
0270		<1%	348	$285.56
73610		<1%	14	$273.55
90734		<1%	336	$270.00
96361	Intravenous infusion, hydration; each additional hour	<1%	15	$262.55
88150		<1%	134	$250.00
87340		<1%	369	$239.25
0637		<1%	47	$238.96
81002		<1%	967	$234.64
A7038	Filter, disposable, used with positive airway pressure device	<1%	27	$227.53
81329		<1%	28	$217.00
82607		<1%	460	$216.97
84550		<1%	938	$214.73
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	209	$204.36
82274		<1%	381	$199.68
86140		<1%	572	$196.50
E0114	Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips	<1%	13	$188.37
82043		<1%	1,050	$187.39
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	27	$183.80
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	71	$180.60
87077		<1%	224	$177.05
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	<1%	66	$175.63
83970		<1%	39	$168.85
84436		<1%	788	$157.99
82565		<1%	216	$153.91
87081		<1%	323	$151.29
83550		<1%	446	$145.56
76830	Ultrasound, transvaginal	<1%	13	$140.73
J7030	Infusion, normal saline solution , 1000 cc	<1%	19	$135.42
99401		<1%	283	$131.17
86769		<1%	13	$125.55
A4267	Contraceptive supply, condom, male, each	<1%	42	$122.91
G0444	Annual depression screening, 5 to 15 minutes	<1%	76	$119.48
90672		<1%	139	$117.00
80074		<1%	294	$116.81
83655		<1%	377	$109.54
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	1,598	$108.78
84460		<1%	149	$105.56
86480		<1%	229	$104.12
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	44	$100.00
84481		<1%	107	$96.83
A4590	Special casting material (e.g., fiberglass)	<1%	76	$90.00
3078F		<1%	3,061	$87.98
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	51	$81.90
84100		<1%	162	$81.45
84479		<1%	656	$70.43
97035		<1%	506	$68.70
82550		<1%	77	$67.72
92551		<1%	1,102	$63.98
80051		<1%	16	$60.54
83013		<1%	12	$59.28
G9920	Screening performed and negative	<1%	1,232	$58.00
87210		<1%	30	$52.44
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	48	$50.00
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	373	$49.92
84480		<1%	401	$48.61
86431		<1%	318	$46.53
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	311	$45.00
86762		<1%	288	$43.44
86850		<1%	532	$41.94
82040		<1%	82	$39.56
3074F		<1%	3,128	$37.50
84520		<1%	41	$36.87
82950		<1%	239	$36.30
84146		<1%	18	$34.05
83001		<1%	13	$31.12
83002		<1%	12	$31.04
90744		<1%	42	$27.00
90680		<1%	104	$27.00
87806		<1%	13	$26.22
92015	Determination of refractive state	<1%	630	$25.00
84450		<1%	157	$23.88
V2020	Frames, purchases	<1%	13	$21.31
90710		<1%	14	$18.00
90723		<1%	48	$18.00
99442		<1%	419	$16.75
82310		<1%	15	$16.32
82150		<1%	27	$14.40
99173		<1%	1,734	$13.34
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	12	$12.00
82248		<1%	25	$11.35
82962		<1%	800	$9.90
96156		<1%	61	$8.41
83050		<1%	597	$8.08
80069		<1%	54	$7.52
84075		<1%	28	$7.36
82247		<1%	27	$7.16
20553		<1%	41	$7.03
84155		<1%	15	$2.90
85651		<1%	13	$1.88
1160F		0%	683	$0.00
1159F		0%	877	$0.00
84295		0%	62	$0.00
77067	Screening mammography, bilateral, including computer-aided detection	0%	545	$0.00
99051		0%	258	$0.00
90621		0%	12	$0.00
86677		0%	15	$0.00
86318		0%	51	$0.00
A0424	Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review)	0%	316	$0.00
83026		0%	56	$0.00
92081		0%	670	$0.00
90472	Immunization administration, each additional vaccine (list separately)	0%	230	$0.00
64495		0%	138	$0.00
G8752	Most recent systolic blood pressure < 140 mmhg	0%	65	$0.00
96160		0%	279	$0.00
81401		0%	25	$0.00
85014		0%	101	$0.00
85007		0%	256	$0.00
87150		0%	118	$0.00
A0382	Bls routine disposable supplies	0%	63	$0.00
3077F		0%	46	$0.00
81479	Unlisted molecular pathology procedure	0%	26	$0.00
A0422	Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation	0%	113	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	18	$0.00
3725F		0%	45	$0.00
0521F		0%	28	$0.00
J9035	Injection, bevacizumab, 10 mg	0%	12	$0.00
91300		0%	17	$0.00
G8783	Normal blood pressure reading documented, follow-up not required	0%	47	$0.00
86696		0%	15	$0.00
2022F		0%	84	$0.00
90461		0%	12	$0.00
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	0%	18	$0.00
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)	0%	12	$0.00
0002A		0%	14	$0.00
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	0%	15	$0.00
82465		0%	16	$0.00
90685		0%	13	$0.00
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	0%	18	$0.00
84403		0%	12	$0.00
90647		0%	53	$0.00
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	0%	395	$0.00
A0420	Ambulance waiting time (als or bls), one half (1/2) hour increments	0%	98	$0.00
A0999	Unlisted ambulance service	0%	119	$0.00
92499		0%	265	$0.00
G8754	Most recent diastolic blood pressure < 90 mmhg	0%	98	$0.00
0001A		0%	33	$0.00
99406		0%	380	$0.00
1000F		0%	12	$0.00
90698		0%	87	$0.00
4000F		0%	385	$0.00
S9451	Exercise classes, non-physician provider, per session	0%	170	$0.00
G8510	Screening for depression is documented as negative, a follow-up plan is not required	0%	311	$0.00
1036F		0%	180	$0.00
64494		0%	141	$0.00
94761		0%	110	$0.00
99050		0%	272	$0.00
3079F		0%	225	$0.00
87040		0%	154	$0.00
76641		0%	171	$0.00
A0398	Als routine disposable supplies	0%	71	$0.00
90688		0%	12	$0.00
64484		0%	112	$0.00
86780		0%	31	$0.00
99447		0%	121	$0.00
3044F		0%	33	$0.00
S9542	Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem	0%	21	$0.00
1126F		0%	45	$0.00
1170F		0%	33	$0.00
H0049	Alcohol and/or drug screening	0%	15	$0.00
80050	General health panel	0%	45	$0.00
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	0%	19	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	161	$0.00
81015		0%	12	$0.00
0012A		0%	58	$0.00
A7037	Tubing used with positive airway pressure device	0%	13	$0.00
99441		0%	13	$0.00
96127		0%	73	$0.00
4050F		0%	14	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	40	$0.00
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	0%	32	$0.00
3075F		0%	12	$0.00
1101F		0%	21	$0.00
0011A		0%	28	$0.00
87205		0%	16	$0.00
99462		0%	43	$0.00
83520		0%	17	$0.00
1220F		0%	13	$0.00
80047		0%	12	$0.00
2000F		0%	17	$0.00
86695		0%	14	$0.00
3080F		0%	12	$0.00
92002		0%	29	$0.00
36410		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialJAYATILAKA, GEORGE (CEO)